EZZ Stock Overview
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
EZZ Life Science Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.81 |
| 52 Week High | AU$0.83 |
| 52 Week Low | AU$0.45 |
| Beta | 0.66 |
| 1 Month Change | 32.52% |
| 3 Month Change | 31.45% |
| 1 Year Change | 39.32% |
| 3 Year Change | 16.43% |
| 5 Year Change | n/a |
| Change since IPO | -32.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| EZZ | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | -1.5% |
| 1Y | 39.3% | -13.3% | 5.7% |
Return vs Industry: EZZ exceeded the Australian Life Sciences industry which returned -13.3% over the past year.
Return vs Market: EZZ exceeded the Australian Market which returned 5.7% over the past year.
Price Volatility
| EZZ volatility | |
|---|---|
| EZZ Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 10.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: EZZ's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine EZZ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Qizhou Qin | ezzlife.com.au |
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand.
EZZ Life Science Holdings Limited Fundamentals Summary
| EZZ fundamental statistics | |
|---|---|
| Market cap | AU$36.64m |
| Earnings (TTM) | AU$3.47m |
| Revenue (TTM) | AU$43.73m |
10.2x
P/E Ratio0.8x
P/S RatioIs EZZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EZZ income statement (TTM) | |
|---|---|
| Revenue | AU$43.73m |
| Cost of Revenue | AU$11.03m |
| Gross Profit | AU$32.70m |
| Other Expenses | AU$29.23m |
| Earnings | AU$3.47m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.078 |
| Gross Margin | 74.78% |
| Net Profit Margin | 7.94% |
| Debt/Equity Ratio | 0% |
How did EZZ perform over the long term?
See historical performance and comparison